TEI 6122

Drug Profile

TEI 6122

Alternative Names: 7-Thiaprostaglandin E1; TFC 612

Latest Information Update: 22 Feb 2001

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Teijin Pharma
  • Class Anticoagulants; Prostaglandins; Vasodilators
  • Mechanism of Action Prostaglandin E1 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Thrombosis

Most Recent Events

  • 22 Feb 2001 Discontinued-II for Thrombosis (PO)
  • 09 Apr 1997 No-Development-Reported for Coronary thrombosis (PO)
  • 18 Jan 1995 Phase-I clinical trials for Coronary thrombosis (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top